Published in PLoS One on August 28, 2012
A gene-based association method for mapping traits using reference transcriptome data. Nat Genet (2015) 1.82
Addiction science: Uncovering neurobiological complexity. Neuropharmacology (2013) 1.50
Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene. Mol Psychiatry (2013) 1.38
Candidate gene studies of a promising intermediate phenotype: failure to replicate. Neuropsychopharmacology (2012) 1.08
Genetic background of extreme violent behavior. Mol Psychiatry (2014) 0.98
Alcohol Dependence Genetics: Lessons Learned From Genome-Wide Association Studies (GWAS) and Post-GWAS Analyses. Alcohol Clin Exp Res (2015) 0.85
Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder. Proc Natl Acad Sci U S A (2014) 0.84
Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease. Public Health Genomics (2014) 0.84
Does COMT genotype influence the effects of d-amphetamine on executive functioning? Genes Brain Behav (2012) 0.83
RNA-binding proteins, neural development and the addictions. Genes Brain Behav (2016) 0.81
Inattention, impulsive action, and subjective response to D-amphetamine. Drug Alcohol Depend (2013) 0.81
Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers. Psychopharmacology (Berl) (2015) 0.80
Interrogation of allelic chromatin states in human cells by high-density ChIP-genotyping. Epigenetics (2014) 0.79
An animal model of differential genetic risk for methamphetamine intake. Front Neurosci (2015) 0.79
Cadherin-based transsynaptic networks in establishing and modifying neural connectivity. Curr Top Dev Biol (2015) 0.77
A common copy number variation (CNV) polymorphism in the CNTNAP4 gene: association with aging in females. PLoS One (2013) 0.77
Amphetamine increases activity but not exploration in humans and mice. Psychopharmacology (Berl) (2015) 0.77
Schizophrenia gene expression profile reverted to normal levels by antipsychotics. Int J Neuropsychopharmacol (2014) 0.76
Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition. Transl Psychiatry (2015) 0.76
A proximity-based method to identify genomic regions correlated with a continuously varying environmental variable. Evol Bioinform Online (2013) 0.76
Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associations. Psychopharmacology (Berl) (2015) 0.76
Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology. J Psychopharmacol (2016) 0.76
A Review of Genome-Wide Association Studies of Stimulant and Opioid Use Disorders. Mol Neuropsychiatry (2016) 0.75
Cerebellum Transcriptome of Mice Bred for High Voluntary Activity Offers Insights into Locomotor Control and Reward-Dependent Behaviors. PLoS One (2016) 0.75
A Preliminary Investigation of Individual Differences in Subjective Responses to D-Amphetamine, Alcohol, and Delta-9-Tetrahydrocannabinol Using a Within-Subjects Randomized Trial. PLoS One (2015) 0.75
Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functions. Mol Med (2017) 0.75
Behavioral and transcriptomic profiling of mice null for Lphn3, a gene implicated in ADHD and addiction. Mol Genet Genomic Med (2016) 0.75
Single nucleotide polymorphism near CREB1, rs7591784, is associated with pretreatment methamphetamine use frequency and outcome of outpatient treatment for methamphetamine use disorder. J Psychiatr Res (2015) 0.75
CDH13 and HCRTR2 May Be Associated with Hypersomnia Symptom of Bipolar Depression: A Genome-Wide Functional Enrichment Pathway Analysis. Psychiatry Investig (2015) 0.75
Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer's disease. PLoS Genet (2017) 0.75
Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults. Psychopharmacology (Berl) (2016) 0.75
A map of human genome variation from population-scale sequencing. Nature (2010) 121.13
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet (2007) 52.68
Population structure and eigenanalysis. PLoS Genet (2006) 37.21
A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet (2009) 30.09
Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet (2008) 15.89
Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet (2007) 15.55
Genetics and beyond--the transcriptome of human monocytes and disease susceptibility. PLoS One (2010) 7.48
Practical issues in imputation-based association mapping. PLoS Genet (2008) 6.76
Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet (2010) 6.49
Exploration, normalization, and genotype calls of high-density oligonucleotide SNP array data. Biostatistics (2006) 5.20
Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A (2003) 4.21
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood (2008) 4.02
pcaMethods--a bioconductor package providing PCA methods for incomplete data. Bioinformatics (2007) 3.84
Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry (1994) 3.64
Genome-wide association study of alcohol dependence. Arch Gen Psychiatry (2009) 3.08
Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am J Hum Genet (2007) 3.05
Rewarding, stimulant, and sedative alcohol responses and relationship to future binge drinking. Arch Gen Psychiatry (2011) 2.71
Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet (2008) 2.53
Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm (Vienna) (2008) 2.43
Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry (2010) 2.41
Genome-wide association scan for five major dimensions of personality. Mol Psychiatry (2008) 2.29
Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs. BMC Genet (2007) 2.24
Genome-wide association studies in pharmacogenomics. Nat Rev Genet (2010) 2.14
Pooled association genome scanning for alcohol dependence using 104,268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism. Am J Med Genet B Neuropsychiatr Genet (2006) 2.09
Analysis of population structure: a unifying framework and novel methods based on sparse factor analysis. PLoS Genet (2010) 2.06
Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc Natl Acad Sci U S A (2006) 2.01
Meta-analysis of genome-wide association studies for personality. Mol Psychiatry (2010) 1.96
Addiction molecular genetics: 639,401 SNP whole genome association identifies many "cell adhesion" genes. Am J Med Genet B Neuropsychiatr Genet (2006) 1.95
Recollections and repercussions of the first inhaled cigarette. Addict Behav (2004) 1.92
Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest (1993) 1.88
Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.86
Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants. Mol Psychiatry (2012) 1.84
Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry (2008) 1.72
Adiponectin concentrations: a genome-wide association study. Am J Hum Genet (2010) 1.70
Genome-wide association scan of trait depression. Biol Psychiatry (2010) 1.65
Expression of T-cadherin (CDH13, H-Cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells. J Neurochem (2000) 1.64
Early reactions to cannabis predict later dependence. Arch Gen Psychiatry (2003) 1.59
Dual determinants of drug use in humans: reward and impulsivity. Nebr Symp Motiv (2004) 1.54
Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 1.48
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma. Nat Med (2011) 1.42
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. Mol Psychiatry (2010) 1.39
Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet (2010) 1.38
Genome-wide association identifies candidate genes that influence the human electroencephalogram. Proc Natl Acad Sci U S A (2010) 1.38
Drug preference and mood in humans: diazepam. Psychopharmacology (Berl) (1980) 1.36
Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology (2005) 1.34
Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C. Hum Mol Genet (2011) 1.31
Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology (2006) 1.30
Sensations from initial exposure to nicotine predicting adolescent smoking in China: a potential measure of vulnerability to nicotine. Nicotine Tob Res (2003) 1.27
Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers. Mol Med (2008) 1.27
Biosynthesis and action of neurosteroids. Brain Res Brain Res Rev (2001) 1.23
Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol (2009) 1.21
Administration of progesterone produces mild sedative-like effects in men and women. Psychoneuroendocrinology (2004) 1.21
Developmental trajectory classes in substance use disorder etiology. Psychol Addict Behav (2007) 1.14
Genome-wide association study of comorbid depressive syndrome and alcohol dependence. Psychiatr Genet (2012) 1.14
The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. Eur J Pharmacol (1997) 1.12
Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine. Psychiatr Genet (2010) 1.11
Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. Pharmacogenomics (2010) 1.10
Assessment of abuse liability of stimulant drugs in humans: a methodological survey. Drug Alcohol Depend (1991) 1.10
Deconstruction of vulnerability to complex diseases: enhanced effect sizes and power of intermediate phenotypes. ScientificWorldJournal (2007) 1.09
'Hangover' effects the morning after marijuana smoking. Drug Alcohol Depend (1985) 1.06
Norepinephrine transporter gene variation modulates acute response to D-amphetamine. Biol Psychiatry (2007) 1.04
Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence. PLoS One (2011) 1.00
Impact of the ADHD-susceptibility gene CDH13 on development and function of brain networks. Eur Neuropsychopharmacol (2012) 0.96
A genomewide linkage scan of cocaine dependence and major depressive episode in two populations. Neuropsychopharmacology (2011) 0.96
An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response. Am J Med Genet B Neuropsychiatr Genet (2006) 0.95
Behavioral responses to amphetamines in identical twins. Acta Genet Med Gemellol (Roma) (1983) 0.94
Serotonin transporter genotype and acute subjective response to amphetamine. Am J Addict (2006) 0.94
Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and 'well-state' bipolar patients. Psychoneuroendocrinology (1982) 0.94
Genome-wide association study of personality traits in bipolar patients. Psychiatr Genet (2011) 0.94
Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers. Behav Genet (2010) 0.92
Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women. Psychoneuroendocrinology (2001) 0.92
More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine. Neuropsychopharmacology (2009) 0.92
CDH13 is associated with working memory performance in attention deficit/hyperactivity disorder. Genes Brain Behav (2011) 0.92
First positive reactions to cannabis constitute a priority risk factor for cannabis dependence. Addiction (2009) 0.90
Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1. J Hum Genet (2005) 0.89
Variation in genes encoding the neuroactive steroid synthetic enzymes 5α-reductase type 1 and 3α-reductase type 2 is associated with alcohol dependence. Alcohol Clin Exp Res (2011) 0.87
Effects of acute progesterone administration upon responses to acute psychosocial stress in men. Exp Clin Psychopharmacol (2010) 0.85
Further evidence of association between amphetamine response and SLC6A2 gene variants. Psychopharmacology (Berl) (2009) 0.84
Translational genetic approaches to substance use disorders: bridging the gap between mice and humans. Hum Genet (2011) 0.83
Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients. Pharmacogenomics J (2011) 0.81
Stimulant use and symptoms of abuse/dependence: epidemiology and associations with cannabis use--a twin study. Drug Alcohol Depend (2006) 0.78
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res (2008) 62.07
Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics (2003) 53.11
A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet (2006) 28.32
Modeling linkage disequilibrium and identifying recombination hotspots using single-nucleotide polymorphism data. Genetics (2003) 17.73
Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27
Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature (2010) 16.86
Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet (2007) 15.55
Genes mirror geography within Europe. Nature (2008) 14.23
A comparison of phasing algorithms for trios and unrelated individuals. Am J Hum Genet (2006) 12.45
Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92
Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet (2012) 11.29
Inferring weak population structure with the assistance of sample group information. Mol Ecol Resour (2009) 10.81
Inference of population structure using multilocus genotype data: dominant markers and null alleles. Mol Ecol Notes (2007) 10.11
High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet (2008) 9.68
The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet (2004) 9.37
Genotype imputation with thousands of genomes. G3 (Bethesda) (2011) 8.77
Interpreting principal component analyses of spatial population genetic variation. Nat Genet (2008) 8.49
Evidence for substantial fine-scale variation in recombination rates across the human genome. Nat Genet (2004) 6.99
Practical issues in imputation-based association mapping. PLoS Genet (2008) 6.76
Genome-wide efficient mixed-model analysis for association studies. Nat Genet (2012) 6.62
DNase I sensitivity QTLs are a major determinant of human expression variation. Nature (2012) 6.17
The nature and identification of quantitative trait loci: a community's view. Nat Rev Genet (2003) 3.96
Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am J Hum Genet (2008) 3.61
Sex-specific and lineage-specific alternative splicing in primates. Genome Res (2009) 3.61
High-resolution genetic mapping using the Mouse Diversity outbred population. Genetics (2012) 3.28
Assigning African elephant DNA to geographic region of origin: applications to the ivory trade. Proc Natl Acad Sci U S A (2004) 3.17
Preference for immediate over delayed rewards is associated with magnitude of ventral striatal activity. J Neurosci (2006) 3.10
Rewarding, stimulant, and sedative alcohol responses and relationship to future binge drinking. Arch Gen Psychiatry (2011) 2.71
Automating resequencing-based detection of insertion-deletion polymorphisms. Nat Genet (2006) 2.61
Polygenic modeling with bayesian sparse linear mixed models. PLoS Genet (2013) 2.59
Dissecting the regulatory architecture of gene expression QTLs. Genome Biol (2012) 2.51
A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet (2003) 2.51
A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. Nature (2013) 2.46
A statistical framework for joint eQTL analysis in multiple tissues. PLoS Genet (2013) 2.46
msHOT: modifying Hudson's ms simulator to incorporate crossover and gene conversion hotspots. Bioinformatics (2006) 2.45
Genome-wide association of lipid-lowering response to statins in combined study populations. PLoS One (2010) 2.43
Biphasic alcohol response differs in heavy versus light drinkers. Alcohol Clin Exp Res (2002) 2.39
Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology (2003) 2.37
Absence of the TAP2 human recombination hotspot in chimpanzees. PLoS Biol (2004) 2.22
Conservation of hotspots for recombination in low-copy repeats associated with the NF1 microdeletion. Nat Genet (2006) 2.11
Genome-wide association studies and the problem of relatedness among advanced intercross lines and other highly recombinant populations. Genetics (2010) 2.06
Analysis of population structure: a unifying framework and novel methods based on sparse factor analysis. PLoS Genet (2010) 2.06
Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro. J Interferon Cytokine Res (2004) 1.98
Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav (2002) 1.94
Behavioral and biological indicators of impulsivity in the development of alcohol use, problems, and disorders. Alcohol Clin Exp Res (2010) 1.87
Acute-alcohol effects on the Experiential Discounting Task (EDT) and a question-based measure of delay discounting. Pharmacol Biochem Behav (2006) 1.83
Genetic analysis in the Collaborative Cross breeding population. Genome Res (2011) 1.74
Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice. J Clin Invest (2009) 1.67
Behavioral differences among C57BL/6 substrains: implications for transgenic and knockout studies. J Neurogenet (2008) 1.66
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2003) 1.65
Using DNA to track the origin of the largest ivory seizure since the 1989 trade ban. Proc Natl Acad Sci U S A (2007) 1.56
Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci (2008) 1.55
Interactions between glucocorticoid treatment and cis-regulatory polymorphisms contribute to cellular response phenotypes. PLoS Genet (2011) 1.49
Social neuroscience and its potential contribution to psychiatry. World Psychiatry (2014) 1.48
Next generation analytic tools for large scale genetic epidemiology studies of complex diseases. Genet Epidemiol (2011) 1.47
Menstrual cycle phase and responses to drugs of abuse in humans. Drug Alcohol Depend (2006) 1.47
QTLRel: an R package for genome-wide association studies in which relatedness is a concern. BMC Genet (2011) 1.46
Effects of sleep deprivation on impulsive behaviors in men and women. Physiol Behav (2007) 1.44
Incubation of cue-induced cigarette craving during abstinence in human smokers. Biol Psychiatry (2011) 1.44
A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior. PLoS One (2009) 1.44
Amping up effort: effects of d-amphetamine on human effort-based decision-making. J Neurosci (2011) 1.43
Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biol Psychiatry (2010) 1.39
Variation in human recombination rates and its genetic determinants. PLoS One (2011) 1.39
Bupropion improves attention but does not affect impulsive behavior in healthy young adults. Exp Clin Psychopharmacol (2008) 1.36
Comparative RNA sequencing reveals substantial genetic variation in endangered primates. Genome Res (2011) 1.36
Integrative modeling of eQTLs and cis-regulatory elements suggests mechanisms underlying cell type specificity of eQTLs. PLoS Genet (2013) 1.34
Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology (2005) 1.34
Combating the illegal trade in African elephant ivory with DNA forensics. Conserv Biol (2008) 1.34
Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers. J Clin Psychopharmacol (2008) 1.34
Fast and accurate estimation of the population-scaled mutation rate, theta, from microsatellite genotype data. Genetics (2007) 1.32
Test-retest characteristics of the Balloon Analogue Risk Task (BART). Exp Clin Psychopharmacol (2008) 1.32
Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2008) 1.31
Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences. Nicotine Tob Res (2006) 1.31
Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology (2006) 1.30
Effect of tryptophan depletion on impulsive behavior in men with or without a family history of alcoholism. Behav Brain Res (2002) 1.28
Genetics of caffeine consumption and responses to caffeine. Psychopharmacology (Berl) (2010) 1.27
Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (Berl) (2009) 1.27
GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend (2002) 1.27
Genetic variation and population substructure in outbred CD-1 mice: implications for genome-wide association studies. PLoS One (2009) 1.27
The contribution of RNA decay quantitative trait loci to inter-individual variation in steady-state gene expression levels. PLoS Genet (2012) 1.25
Differential effects of nicotine on alcohol consumption in men and women. Psychopharmacology (Berl) (2006) 1.24
Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users. Psychopharmacology (Berl) (2006) 1.24
The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology (Berl) (2012) 1.22
Significance thresholds for quantitative trait locus mapping under selective genotyping. Genetics (2007) 1.22
Smoking topography in response to denicotinized and high-yield nicotine cigarettes in adolescent smokers. J Adolesc Health (2006) 1.22
Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol (2009) 1.21
Effects of morphine and naltrexone on impulsive decision making in rats. Psychopharmacology (Berl) (2004) 1.21
Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology (Berl) (2012) 1.21
Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers. Alcohol Clin Exp Res (2003) 1.20